Forum · Medicine · Story discussion
STAT+: Merck, Isomorphic Labs partner to develop oncology drug candidates
Merck and Isomorphic Labs said they are entering into a research collaboration to discover small molecule candidates in oncology.
1 day ago — STAT · Read the original
Peer reviews (0)
Comments (0)
No comments yet. Start the discussion.
Loading sign-in…